Conference Documentation: Pre-Filled Syringes West Coast 2016
SMi proudly presents its inaugural event of the premier Pre-Filled Syringes series to San Diego in June 2016!
The prefilled syringes (PFS) market is poised to account for exponential growth and account for $6 billion revenue by the end of 2020.* The market has witnessed continual advancements in device design with enhanced safety and usability by patients through human factor engineering. Nonetheless, challenges surrounding biologic drug stability, manufacturing and competition from other drug delivery technologies remain key concerns amongst pharma and medical device manufacturers.
Emulating on SMi’s successful PFS series, we are bringing this must-attend event to the West Coast, where we will focus more on the innovative technologies. Join us today to discuss with your industry colleagues to accelerate PFS development!
San Diego has been known for being a hub of healthcare and biotech innovation center. As of 2013, San Diego has the second-largest biotech cluster in the US, below the Boston area and above the San Francisco Bay Area.
More than 400 biotech companies are homed in the region. Major companies like Neurocrine Biosciences and Nventa Biopharmaceuticals are headquartered in SD, while many other established biotech companies - including BD Biosciences, Biogen Idec, Merck, Pfizer, Celgene and Vertex, also have their offices and R&D facilities in the heart of area, this provides the optimal setting for our premier Pre-Filled Syringes Conference & Exhibition, which you will meet like-minded Pre-Fillled Syringes experts at this meeting!
Electronic Access - Single User Fulfilled By Publisher